Missing the Opportunity to Fund FDA

NIH has seen its budget double during the Clinton and Bush Administrations, while FDA funding has remained essentially flat over the same period. It's time to correct the discrepancy.

By William Hubbard

Imagine this scenario: There’s an industry in the US making a range of products that save millions of lives each...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Agency Leadership

More from Pink Sheet